PubMed COVID-19 Clinical Care

This report presents an atypical case of neuroretinitis in a post-transplant patient. A man in his 40s presented to a provincial ophthalmology service with unilateral left visual loss. He was immunosuppressed following orthotopic liver

When the COVID-19 pandemic first emerged in early 2020, healthcare and bureaucratic systems worldwide were caught off guard and largely unprepared to deal with the scale and severity of the outbreak. In Italy, this led to a severe underreporting of

No abstract

The COVID-19 pandemic challenged occupational medicine, while its focus had already shifted from occupational diseases to work-related illnesses. Such a broader scope allowed the inclusion of transmissible diseases among the causes for concern in

Ionizable lipid nanoparticles (LNPs) pivotal to the success of COVID-19 mRNA (messenger RNA) vaccines hold substantial promise for expanding the landscape of mRNA-based therapies. Nevertheless, the risk of mRNA delivery to off-target tissues

No abstract

The memory B cell response consists of phenotypically distinct subsets that differ in their ability to respond upon antigen re-encounter. However, the pathways regulating the development and function of memory B cell subsets are poorly understood

The COVID-19 pandemic originated in 2019 and has become an endemic disease that we must learn to live with, similar to other strains of influenza. The Organization (WHO) declared on May 5, 2023, in Geneva, Switzerland, the end of the Public Health

[This corrects the article DOI: 10.1371/journal.pone.0284248.].

The currently available coronavirus disease 2019 (COVID-19) vaccines in South Korea include mRNA (Moderna^(®) and Pfizer^(®)) and adenoviral vector (AstraZeneca^(®) and Janssen^(®)) vaccines. Dermatologic side effects of COVID-19 vaccines range from